[HTML][HTML] Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications

X Zhou, X Ao, Z Jia, Y Li, S Kuang, C Du… - Frontiers in …, 2022 - frontiersin.org
Cancer is one of the most frequently diagnosed malignant diseases worldwide, posing a
serious, long-term threat to patients' health and life. Systemic chemotherapy remains the first …

[HTML][HTML] Promising applications of nanotechnology in inhibiting chemo-resistance in solid tumors by targeting epithelial-mesenchymal transition (EMT)

M Tangsiri, A Hheidari, M Liaghat, M Razlansari… - Biomedicine & …, 2024 - Elsevier
The resistance of cancer cells to chemotherapy, also known as chemo-resistance, poses a
significant obstacle to cancer treatment and can ultimately result in patient mortality …

[HTML][HTML] High expression of cuproptosis-related SLC31A1 gene in relation to unfavorable outcome and deregulated immune cell infiltration in breast cancer: an …

L Li, L Li, Q Sun - BMC bioinformatics, 2022 - Springer
Cuproptosis induction represents a promising alternative for immunotherapies and targeted
therapies in breast cancer. This study aimed to investigate the prognostic and biological …

Embedded bioprinting of breast tumor cells and organoids using low‐concentration collagen‐based bioinks

W Shi, S Mirza, M Kuss, B Liu, A Hartin… - Advanced …, 2023 - Wiley Online Library
Bioinks for 3D bioprinting of tumor models should not only meet printability requirements but
also accurately maintain and support phenotypes of tumor surrounding cells to recapitulate …

[HTML][HTML] The pRb/RBL2-E2F1/4-GCN5 axis regulates cancer stem cell formation and G0 phase entry/exit by paracrine mechanisms

CH Chang, F Liu, S Militi, S Hester, R Nibhani… - Nature …, 2024 - nature.com
The lethality, chemoresistance and metastatic characteristics of cancers are associated with
phenotypically plastic cancer stem cells (CSCs). How the non-cell autonomous signalling …

[HTML][HTML] The TH1902 docetaxel peptide-drug conjugate inhibits xenografts growth of human SORT1-positive ovarian and triple-negative breast cancer stem-like cells

M Demeule, C Charfi, JC Currie, A Zgheib… - Pharmaceutics, 2022 - mdpi.com
Background: Breast and ovarian cancer stem cells (CSC) can contribute to the invasive and
chemoresistance phenotype of tumors. TH1902, a newly developed sortilin (SORT1) …

[HTML][HTML] Pharmacological anti-tumor effects of natural Chamaecyparis obtusa (siebold & zucc.) endl. Leaf extracts on breast cancer

YJ Kwon, EB Seo, SK Kim, HS Lee, H Lee… - Journal of …, 2023 - Elsevier
Ethnopharmacological relevance Chamaecyparis obtusa (C. obtusa, cypress species) is a
plant that grows mainly in the temperate Northern Hemisphere and has long been used as a …

[HTML][HTML] Correlation between the Warburg effect and progression of triple-negative breast cancer

S Liu, Y Li, M Yuan, Q Song, M Liu - Frontiers in Oncology, 2023 - frontiersin.org
Negative expression of the estrogen receptor, progesterone receptor, and human epidermal
growth factor receptor-2 disqualifies triple-negative breast cancer (TNBC) as a candidate for …

[HTML][HTML] Extracellular vesicles in breast cancer: from biology and function to clinical diagnosis and therapeutic management

S Loric, JA Denis, C Desbene, M Sabbah… - International journal of …, 2023 - mdpi.com
Breast cancer (BC) is the first worldwide most frequent cancer in both sexes and the most
commonly diagnosed in females. Although BC mortality has been thoroughly declining over …

[HTML][HTML] Addressing the clinical feasibility of adopting circulating miRNA for breast cancer detection, monitoring and management with artificial intelligence and …

L Ling, AF Aldoghachi, ZX Chong, WY Ho… - International journal of …, 2022 - mdpi.com
Detecting breast cancer (BC) at the initial stages of progression has always been regarded
as a lifesaving intervention. With modern technology, extensive studies have unraveled the …